Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 270-276

  Santos, Sara S ^a   Lorenzoni, Alessandra ^a   Pegoraro, Natháli S ^a   Denardi, Laura B ^a   Alves, Sydney H ^a   Schaffazick, Scheila R ^a   Cruz, Letícia ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antifungal activity; Candida; Clotrimazole; Coconut oil; Eudragit RS100; Nanocapsules

Indexed keywords

ANTIFUNGAL AGENT; CATION; CLOTRIMAZOLE; COCONUT OIL; NANOCAPSULE; POLYMER; VEGETABLE OIL;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PARTICLE SIZE; SURFACE PROPERTY;

ADMINISTRATION, INTRAVAGINAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; CATIONS; CLOTRIMAZOLE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; NANOCAPSULES; PARTICLE SIZE; PLANT OILS; POLYMERS; SURFACE PROPERTIES;

EID: 84893498557     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.01.011     Document Type: Article

References (46)

1. Mora-Huertas C.E., Fessi H., Elaissari A. Int. J. Pharm. 2010, 385:113.
2. Alonso M.J. Biomed. Pharmacother 2004, 58:168.
3. Kumari A., Kumar Yadav S., Yadav S.C. Colloids Surf. B 2010, 75:1.
4. Quintanar-Guerrero D., Allémann E., Fessi H., Doelker E. Drug. Dev. Ind. Pharm 1998, 24:1113.
5. Schaffazick S.R., Freitas L.L., Pohlmann A.R., Guterres S.S. Quim Nova 2003, 25:726.
6. Couvreur P., Gillian B., Fattal E., Legrand P., Vauthier V. Crit. Rev Ther. Drug Carrier Syst. 2002, 19:99.
7. Preetz C., Rübe A., Reiche I., Hause G., Mäder K. Nanomedicine 2008, 4:106.
8. Limayem I.B., Charcosset C., Sfar S., Fessi H. Int. J. Pharm. 2006, 325:124.
9. Adamczak M., Krok M., Pamuła E., Posadowska U., Szczepanowicz K., Barbasz J., Warszynski P. Colloids Surf. B 2013, 110:1.
10. Friedrich R.B., Fontana M.C., Beck R.C.R. Quim Nova 2008, 31:1131.
11. Almeida J.S., Jezur L., Fontana M.C., Paese K., Silva C.B., Pohlmann A.R., Guterres S.S., Beck R.C.R. Lat. Am. J. Pharm. 2009, 28:165.
12. Contri R.V., Ribeiro K.L.F., Fiel L.A., Pohlmann A.R., Guterres S.S. J. Exp. Nanosci. 2012, 1.
13. Yong J.W.H., Ge L., Ng Y.F., Tan S.N. Molecules 2009, 14:5144.
14. British Pharmacopeia, British Pharmacopeia Comission, vol. 1, Her Majesty Stationary Office, London, 2010.
15. Ogbolu D.O., Oni A.A., Daini O.A., Oloko A.P. J. Med. Food 2007, 10:384.
16. Agarwal V., Lal P., Pruthi V. J. Microbiol. Immunol. Infect. 2010, 43:447.
17. DebMandal M., Mandal S. Asian Pac. J. Trop. Med. 2011, 4:241.
18. Nevin K.G., Rajamohan T. Food Chem. 2006, 99:260.
19. Marina A.M., Man Y.B., Nazimah S.A., Amin I. Int. J. Food Sci. Nutr. 2009, 60:114.
20. Guarte R.C., Mfihlbauer W., Kellert M. Postharvest. Biol. Tec. 1996, 9:361.
21. U. Bazylinska, A. Lewinska, L. Lamch, K.A. Wilk, Colloids Surf. A: Physicochem. Eng. Aspects (2013), doi:10.1016/j.colsurfa.2013.02.023.
22. Lee C.M., Jeong H.J., Park J-W., Kim J., Lee K-Y. Macromol. Res. 2008, 16:682.
23. Kang K.C., Jeong N.H., Lee C.I., Pyo H-B. J. Ind. Eng. Chem. 2009, 15:529.
24. Fang J.Y., Leu Y.L., Chang C.C., Lin C.H., Tsai Y.H. Drug Deliv. 2004, 11:97.
25. Piriyaprasarth S., Sriamornsak P., Chansiri G., Promboot W., Imerb U., Sumpoung D. Adv. Mater. Res. 2012, 506:429.
26. Sudeendra R.B., Shivakumar H.G. Trop. J. Pharm. Res. 2010, 9:339.
27. Santos S.S., Ferreira L.M., Schaffazick S.R., Cruz L. Lat. Am. J. Pharm 2012, 31:482.
28. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Int. J. Pharm. 1983, 15:25.
29. Cruz L., Soares L.U., Dalla Costa T., Mezzalira G., Silveira N., Guterres S.S., Pohlmann A.R. Int. J. Pharm. 2006, 313:198.
30. Peppas N.A. Pharm. Acta Helv. 1985, 60:110.
31. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing Yeasts, 3rd ed. Approved Standard M27-A3, Wayne, PA, 2008.
32. Johnson M.D., Macdougall C., Ostrosky L., Perfect J.R., Rex J.H. Antimicrob. Agents Chemother. 2004, 48:693.
33. Guterres S.S., Weiss V., Freitas L.L., Pohlmann A.R. Drug Deliv. 2000, 7:195.
34. Schaffazick S.R., Pohlmann A.R., Mezzalira G., Guterres S.S. J. Braz. Chem. Soc. 2006, 17:562.
35. Pandey R., Ahmad Z., Sharma S., Khuller G.K. Int. J. Pharm. 2005, 301:268.
36. Bassi P., Kaur G. Expert Opin. Ther. Pat. 2012, 22:1019.
37. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Int. J. Pharm. 2004, 278:71.
38. Perugini P., Simeoni S., Scalia S., Genta I., Modena T., Conti B., Pavanetto F. Int. J. Pharm. 2002, 246:37.
39. Ourique A.F., Pohlmann A.R., Guterres S.S., Beck R.C.R. Int. J. Pharm. 2008, 352:1.
40. Almeida J.S., Lima F., Ros S., Bulhões L.O.S., Carvalho L.M., Beck R.C.R. Nanoscale Res. Lett. 2010, 5:1603.
41. Bachhav Y.G., Patravale V.B. AAPS Pharmscitech. 2009, 10:476.
42. R.C. Rowe, P.J., Sheskey, W.G., Cook, M.E. Fenton, Handbook of Pharmaceutical Excipients, 6rd edition, 2009.
43. Santos S.S., Lorenzoni A., Ferreira L.M., Mattiazzi J., Adams A.I.H., Denardi L.B., Alves S.H., Schaffazick S.R., Cruz L. Mater. Sci. Eng. C 2013, 3:1389.
44. Dillen K., Bridts C., Cos V.P., Vandervoort J., Augustyns K., Stevens W., Ludwig A. Int. J. Pharm. 2008, 349:234.
45. Esmaeili F., Hosseini-Nasr M., Rad-Malekshahi M., Samadi N., Atyabi F., Dinarvand R. Nanomed. Nanotech. Biol. Med. 2007, 3:161.
46. Peng H.S., Liu X.J., Lv G.X., Sun B., Kong Q.F., Zhai D.X., Wang Q., Zhao W., Wang G.Y., Wang D.D., Li H.L., Jin L.H., Kostulas N. Int. J. Pharm. 2008, 352:29.